Filing Details

Accession Number:
0001250853-18-000013
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-01-04 20:41:15
Reporting Period:
2018-01-02
Accepted Time:
2018-01-04 20:41:15
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1561743 Kindred Biosciences Inc. KIN Pharmaceutical Preparations (2834) 461160142
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1593867 Raymond Townsend C/O Kindred Biosciences, Inc.
1555 Bayshore Highway, Suite 200
Burlingame CA 94010
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-01-02 6,419 $3.45 18,419 No 4 M Direct
Common Stock Disposition 2018-01-02 6,419 $9.45 12,000 No 4 S Direct
Common Stock Acquisiton 2018-01-02 11,142 $3.45 23,142 No 4 M Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2018-01-02 6,419 $0.00 6,419 $3.45
Common Stock Stock Option (right to buy) Disposition 2018-01-02 11,142 $0.00 11,142 $3.45
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
37,581 2026-01-08 No 4 M Direct
26,439 2026-01-08 No 4 M Direct
Footnotes
  1. The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 30, 2017.
  2. The option vested 25% quarterly following January 8, 2016, the date of grant.